New and Approved: FDA’s 2024 Drug Lineup
1.5 Credits / General Pharmacy
View More
Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
2.0 Credits / General Pharmacy
View More
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
2.0 Credits / Pain Management
View More
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia
1.5 Credits / Neurology, Psychiatry
View More
Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens
1.5 Credits / Hematologic Cancer, Hematology, Oncology
View More
Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management
1.5 Credits / Oncology, Hematology
View More
Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative
1.5 Credits / Cardiology
View More
Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions
January 26th 2026Skilled nursing facilities (SNFs) with a high volume of referred patients with Alzheimer disease and related dementias may work harder to manage care transitions with less availability of resources that enable high-quality handoffs.
Balancing Innovation With Administrative Burdens in Cancer Care
At the Orlando session of the Institute for Value-Based Medicine, clinicians delivering cancer care in Central Florida address restrictions from Medicare Advantage plans, which can affect access to innovative treatments for breast cancer, myeloma, and bladder cancer.